Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

Neurocrine Biosciences, Inc.

NBIX ✓ COMPLIANTFree checks used up today ☆ Track — members
NASDAQ · Healthcare · Pharmaceuticals ·
USA Large Cap Analyst: BUY
Last Close
$143.96
▼ -1.55%
Market Cap $14.63B · Vol 434.87K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
21.10
FWD: 15.77
Market Cap
$14.63B
Large Cap
Div Yield
N/A
N/A
EPS Growth
+49.90%
YoY
RSI (14)
32.18
Momentum
Beta
0.40
vs Market
52W High
$186.12
21.43% below
52W Low
$122.15
19.72% above
Volume
434.87K
Avg 420.49K
P/B
4.36
Price-to-book
ROE
16.38%
Return on equity
Free Float
98.87%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, Neurocrine Biosciences, Inc. (NBIX) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NBIX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
-8.43%
1M
-5.64%
3M
-9.05%
6M
+12.75%
YTD
+1.50%
1Y
-0.87%
3Y
+27.27%
5Y
+50.73%
Financials & Valuation
TTM · Annual
Total Revenue$2.86B
Net Income$478.60M
Revenue Growth (YoY)+39.49%
Gross Margin98.18%
Operating Margin22.25%
Net Profit Margin16.73%
ROE16.38%
ROA · ROIC16.90% · 16.38%
P/E Ratio21.10
Forward P/E (FY1)15.77
PEG Ratio0.73
P/S5.08
P/B4.36
P/FCF19.42
EPS Growth+49.90%
Outstanding Shares101.65M
Technical Indicators
50-Day SMA$161.57
200-Day SMA$147.90
RSI (14)32.18
Beta0.40
52-Week High$186.12
52-Week Low$122.15
Volume Today434.87K
Avg Daily Volume (30D)420.49K
Relative Volume1.03x
Volatility (10D)30.16
Volatility (30D)26.75
Free Float98.87%
AAOIFI Certified Shariah Advisor and Auditor certificate